Nicola Morelli

Dr. Nicola Morelli

Guglielmo da Saliceto Hospital, Piacenza, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Radiology
Verified
Journal Article
Closed access
DCDavide Colombi
Davide Colombi
FBFlavio C. Bodini
Flavio C. Bodini
MPMarcello Petrini
Marcello Petrini
GMGabriele Maffi
Gabriele Maffi
NMNicola Morelli
Nicola Morelli
EMEmanuele Michieletti
Emanuele Michieletti
Background Computed tomography (CT) of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease depicts the extent of lung involvement in COVID-19 pneumonia. Purpose The a...

14 April 2020 in European Neurology
Verified
Journal Article
Closed access
PDF file
NMNicola Morelli
Nicola Morelli
EREugenia Rota
Eugenia Rota
CTChiara Terracciano
Chiara Terracciano
Paolo ImmovilliPaolo Immovilli
Paolo Immovilli
MSMarco Spallazzi
Marco Spallazzi
DGDonata Guidetti
Donata Guidetti
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

16 December 2008 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
NMNicola Morelli
Nicola Morelli
IPIlaria Pesaresi
Ilaria Pesaresi
GCGianfranco Cafforio
Gianfranco Cafforio
MMMaria Rosaria Maluccio
Maria Rosaria Maluccio
SGSara Gori
Sara Gori
LMLuigi Murri
Luigi Murri
We have investigated the cerebral activation centre in four patients with episodic cluster headache (CH) with functional magnetic resonance imaging (f-MRI). The patients underwent MRI scans for anatomical and functional data acquisition in the asymptomatic state, during a headache attack and after subcutaneous administration of sumatriptan. Anatomical images were acquired by means of 3D-MPRAGE sequences and f-MRI images were obtained by means of echo-planar imaging. Data was analysed using the BrainVoyager QX version 1.7.81 software package. In all patients, the data showed significant hypothalamic activation of the hypothalamus ipsilateral to the pain side, attributable to a headache attack. Overall, we have demonstrated the anatomical location of central nervous system activation by means the first f-MRI study in CH patients. f-MRI offers a good balance of spatial and temporal resolution, and this method of study appears appropriate for investigating the pathogenetic aspects of primary headaches. Positron emission tomography and f-MRI may be regarded as little or no importance in a clinical context, they do, however, offer great potential for the exploration of headache physiopathology and the effects of pharmacological treatment.

20 July 2005 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
SGS. Gori
S. Gori
NMNicola Morelli
Nicola Morelli
MMM. Maestri
M. Maestri
MFM. Fabbrini
M. Fabbrini
EBE. Bonanni
E. Bonanni
LML. Murri
L. Murri
Clinical observations show that migraine attacks have a seasonal, menstrual and circadian timing, suggesting a role of chronobiological mechanisms and their alterations in the disease, but little experimental data exists about this issue. The aim of this study was to estimate sleep quality chronotypes and the possible circadian timing of attacks in migraneurs. One hundred patients suffering from migraine without aura according to the IHS criteria (2004), and 30 controls were enrolled. Morning and evening type subjects were more represented in migraine patients than in controls and showed a tendency towards worse sleep quality and higher disability. Forty–two percent of migraineurs presented more than 75% of their attacks at night. Morning and evening types rather than intermediate and differences between real and preferred times may represent stressors that can worsen the disease. A preferential timing for occurrence of migraine attacks during the night and early morning hours was documented.

1 December 2020 in European Journal of Radiology
Verified
Journal Article
Closed access
DCDavide Colombi
Davide Colombi
MPMarcello Petrini
Marcello Petrini
GMGabriele Maffi
Gabriele Maffi
GVGabriele D. Villani
Gabriele D. Villani
FBFlavio C. Bodini
Flavio C. Bodini
EMEmanuele Michieletti
Emanuele Michieletti

8 October 2014 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
DGDonata Guidetti
Donata Guidetti
Eugenia RotaEugenia Rota
Eugenia Rota
NMNicola Morelli
Nicola Morelli
Paolo ImmovilliPaolo Immovilli
Paolo Immovilli
Several comorbidities are associated to migraine. Recent meta-analyses have consistently demonstrated a relationship between migraine and stroke, which is well-defined for ischaemic stroke and migraine with aura, even stronger in females on oral contraceptives or smokers. However, there seems to be no clear-cut association between stroke in migraineurs and the common vascular risk factors, at least in the young adult population. Migraineurs also run an increased risk of hemorrhagic stroke, while the association between migraine and cardiovascular disease remains poorly defined. Another aspect is the relationship between migraine and the presence of silent brain lesions. It has been demonstrated that there is an increased frequency of ischaemic lesions in the white matter of migraineurs, especially silent infarcts in the posterior circulation territory in patients with at least 10 attacks per month. Although there is a higher prevalence of patent foramen ovale (PFO) in migraineurs, the relationship between migraine and PFO remains controversial and PFO closure is not a recommended procedure to prevent migraine. As an increased frequency of cervical artery dissections has been observed in migrainous patients, it has been hypothesized that migraine may represent a predisposing factor for cervical artery dissection. There still remains the question as to whether migraine should be considered a true “vascular disease” or if the comorbidity between migraine and cerebrovascular disease may have underlying shared risk factors or pathophysiological mechanisms. Although further studies are required to clarify this issue, current evidence supports a clinical management where MA patients should be screened for other concomitant vascular risk factors and treated accordingly.